Halozyme Therapeutics reported $112.1M in Trade Debtors for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
DBV Technologies DBVT:US 4.51M 4.51M
Acadia Pharmaceuticals ACAD:US $ 63.48M 1.86M
Agios Pharmaceuticals AGIO:US $ 5.9M 1.53M
Alnylam Pharmaceuticals ALNY:US $ 156.53M 42.04M
Amarin AMRN:US $ 110.23M 53.42M
Amgen AMGN:US $ 5077M 182M
Cara Therapeutics CARA:US $ 3.63M 2.48M
Cytokinetics CYTK:US $ 6.06M 45.76M
Esperion Therapeutics ESPR:US 25.12M 2.18M
Intrexon XON:US $ 21.08M 5.59M